Health
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 – StreetInsider.com
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ –Â AbbVie (NYSE: ABBV) today announced the presentation of new data on…
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab) across multiple rheumatic diseases at the American College…
Continue Reading
-
General21 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General15 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News19 hours agoMeticulously crafted home in heart of Noosa Heads
-
General18 hours ago‘Mother’s Day’ solar storm squeezed Earth’s plasmasphere to one-fifth its size